176 related articles for article (PubMed ID: 14680447)
1. Verteporfin ocular photodynamic therapy.
Bakri SJ; Kaiser PK
Expert Opin Pharmacother; 2004 Jan; 5(1):195-203. PubMed ID: 14680447
[TBL] [Abstract][Full Text] [Related]
2. Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.
Keam SJ; Scott LJ; Curran MP
Drugs; 2003; 63(22):2521-54. PubMed ID: 14609361
[TBL] [Abstract][Full Text] [Related]
3. Spotlight on verteporfin in subfoveal choroidal neovascularisation.
Keam SJ; Scott LJ; Curran MP
Drugs Aging; 2004; 21(3):203-9. PubMed ID: 14979737
[TBL] [Abstract][Full Text] [Related]
4. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
Azab M; Benchaboune M; Blinder KJ; Bressler NM; Bressler SB; Gragoudas ES; Fish GE; Hao Y; Haynes L; Lim JI; Menchini U; Miller JW; Mones J; Potter MJ; Reaves A; Rosenfeld PJ; Strong A; Su XY; Slakter JS; Schmidt-Erfurth U; Sorenson JA; ;
Retina; 2004 Feb; 24(1):1-12. PubMed ID: 15076937
[TBL] [Abstract][Full Text] [Related]
5. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.
Verteporfin Roundtable Participants
Retina; 2005; 25(2):119-34. PubMed ID: 15689800
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy update.
Shuler MF; Borrillo JL; Ho AC
Curr Opin Ophthalmol; 2001 Jun; 12(3):202-6. PubMed ID: 11389347
[TBL] [Abstract][Full Text] [Related]
8. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
9. Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.
Soubrane G; Bressler NM
Br J Ophthalmol; 2001 Apr; 85(4):483-95. PubMed ID: 11264143
[No Abstract] [Full Text] [Related]
10. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sickenberg M; Sternberg P; Aaberg TM; Aaberg TM; Reaves TA;
Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
Verteporfin in Photodynamic Therapy Study Group
Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
[TBL] [Abstract][Full Text] [Related]
13. Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients.
Bessler NM;
Retina; 2004 Aug; 24(4):512-20. PubMed ID: 15300071
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.
; ;
Retina; 2002 Feb; 22(1):6-18. PubMed ID: 11884872
[TBL] [Abstract][Full Text] [Related]
15. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.
Bressler NM
Am J Ophthalmol; 2002 Jan; 133(1):168-9. PubMed ID: 11755871
[No Abstract] [Full Text] [Related]
16. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.
Blinder KJ; Bradley S; Bressler NM; Bressler SB; Donati G; Hao Y; Ma C; Menchini U; Miller J; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Strong HA; Stur M; Su XY; Virgili G; ;
Am J Ophthalmol; 2003 Sep; 136(3):407-18. PubMed ID: 12967792
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
Bressler NM;
Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
[TBL] [Abstract][Full Text] [Related]
19. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8.
Kaiser PK;
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1132-42. PubMed ID: 16538452
[TBL] [Abstract][Full Text] [Related]
20. Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
Isola V; Pece A; Brancato R
Retina; 2004 Aug; 24(4):618-20. PubMed ID: 15300088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
